9th Circ. To Review Class Certification In Diabetes Drug Suit
The Ninth Circuit on Wednesday agreed to review a grant of class certification in a suit by third-party payors alleging that Takeda Pharmaceutical Co. and Eli Lilly & Co. hid risks...To view the full article, register now.
Already a subscriber? Click here to view full article